1,2-dipalmitoylphosphatidylglycerol has been researched along with gadolinium dtpa in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hossann, M; Issels, RD; Lindner, LH; Peller, M; Reiser, M; Syunyaeva, Z; Wang, T; Wiggenhorn, M; Zengerle, A | 1 |
1 other study(ies) available for 1,2-dipalmitoylphosphatidylglycerol and gadolinium dtpa
Article | Year |
---|---|
Non-ionic Gd-based MRI contrast agents are optimal for encapsulation into phosphatidyldiglycerol-based thermosensitive liposomes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Contrast Media; Drug Carriers; Drug Compounding; Gadolinium DTPA; Liposomes; Magnetic Resonance Imaging; Particle Size; Phosphatidylcholines; Phosphatidylglycerols; Surface Properties; Transition Temperature | 2013 |